Dream on. Valeant are bottom feeders - they don't buy at a premium. Like private equity they purchase undervalued entities not overvalued ones like ZLTQ.
Well then valeant should open their eyes and realize that there is nothing honest about Zeltiq, including the numbers that they share. Take a look at why Allergan pulled out. It was for a very good reason. Zeltiq is a dump.
